eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | squamous cell carcinoma of esophagus |
| Comorbidity | C0334246|metastatic squamous cell carcinoma |
| Sentences | 2 |
| PubMedID- 26468007 | Patients with recurrent or metastatic squamous cell carcinoma of the esophagus who had not previously been treated palliative chemotherapy for metastatic disease were eligible. |
| PubMedID- 21888637 | Regarding molecular targeted agents, a randomized phase ii study comparing the epidermal growth factor receptor (egfr) inhibitor, cetuximab in combination with 5-fu and cisplatin (fc), with fc alone was conducted to evaluate the efficacy and safety in first-line metastatic squamous cell carcinoma of the esophagus [26]. |
Page: 1